Neurosci Lett, 2012 · DOI: 10.1016/j.neulet.2012.02.025 · Published: June 25, 2012
After traumatic brain injury and spinal cord injury, the environment around the injury site becomes inhibitory to axon growth, hindering functional recovery. Combination therapies aim to engineer a more permissive environment in the central nervous system (CNS) to promote regeneration. The inhibitory nature of the CNS lesion means that using multiple therapies together might be more effective than single treatments. This review discusses recent attempts to engineer the CNS environment using combined strategies. These combination therapies involve things like delivering neurotrophins (growth factors), transplanting cells, and using biomaterial scaffolds to help rebuild damaged tissue and encourage axon regeneration.
Combination therapies hold promise for enhancing functional recovery following traumatic brain injury (TBI) and spinal cord injury (SCI) by addressing multiple barriers to regeneration.
Strategies such as using Chondroitinase ABC (chABC) can promote axon extension and integration of transplanted cells, facilitating better regeneration of neural pathways.
Targeting specific inhibitory molecules like myelin-associated inhibitors (MAIs) can improve axon regeneration in white matter, leading to more effective therapies.